Article Type
Changed
Tue, 05/21/2019 - 12:17
Display Headline
JOURNAL SCAN
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy

A supplement to Internal Medicine News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.

Topics

 

  • Introduction
  • Prevalence and Etiology
  • Signs and Symptoms
  • Disease Progression
  • Shortcomings of Available Palliative Prescription Therapies
  • Role of Metanx® in Diabetic Neuropathy
  • A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
  • Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats

 

Faculty/Faculty Disclosures

Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia

Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.

Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana

Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.

Author and Disclosure Information

 

 

Publications
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

A supplement to Internal Medicine News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.

Topics

 

  • Introduction
  • Prevalence and Etiology
  • Signs and Symptoms
  • Disease Progression
  • Shortcomings of Available Palliative Prescription Therapies
  • Role of Metanx® in Diabetic Neuropathy
  • A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
  • Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats

 

Faculty/Faculty Disclosures

Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia

Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.

Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana

Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.

A supplement to Internal Medicine News. This supplement was sponsored by Nestlé Health Science-Pamlab, Inc.

Topics

 

  • Introduction
  • Prevalence and Etiology
  • Signs and Symptoms
  • Disease Progression
  • Shortcomings of Available Palliative Prescription Therapies
  • Role of Metanx® in Diabetic Neuropathy
  • A Randomized Trial of Metanx® in Patients with Type 2 Diabetes and Peripheral Neuropathy
  • Efficacy of Metanx® in Treating Peripheral Neuropathy and Increasing Nerve Fiber Density in Zucker Diabetic Fatty Rats

 

Faculty/Faculty Disclosures

Aaron I. Vinik, MD, PhD
Professor of Medicine/Pathology/Neurobiology
Director of Research and Neuroendocrine Unit
Murray Waitzer Endowed Chair of Diabetes Research
Strelitz Diabetes Center for Endocrine and Metabolic Disorders
Eastern Virginia Medical School
Norfolk, Virginia

Dr Vinik has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.

Vivian Fonseca, MD
Tullis–Tulane Alumni Chair in Diabetes
Professor of Medicine
Chief, Section of Endocrinology
Tulane University School of Medicine
New Orleans, Louisiana

Dr Fonseca reports that he has served as a consultant for Nestlé Health Science-Pamlab, Inc., and has received compensation from Nestlé Health Science-Pamlab, Inc., for his participation in preparing this supplement.

Publications
Publications
Article Type
Display Headline
JOURNAL SCAN
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy
Display Headline
JOURNAL SCAN
Summary of Key Articles
Exploring the Role of Metanx® in Diabetic Neuropathy
Sections
Disallow All Ads